abstract |
The present invention relates to a teriparatide acetate-containing liquid pharmaceutical preparation for human subcutaneous administration, which comprises suppressing formation of aspartate isomer of a teriparatide or a salt thereof. SOLUTION: Component 1 (acetate salt of teriparatide) and component 2 (sodium salt, calcium salt, and magnesium salt), and / or hydrochloride salt, which is for human subcutaneous administration It is a liquid pharmaceutical preparation containing one or more salts selected from hydrobromide, acetate, citrate and carbonate, provided that they are components different from component 1. Liquid pharmaceutical preparation whose mass ratio with component 2 is 1:10 or more. 【Selection chart】 None |